Tirelizumab Plus Surgery vs Surgery Alone for Recurrent Nasopharyngeal Carcinoma a Prospecitve, Parallel, Phase II, Randomized Clinical Trial
Latest Information Update: 27 Oct 2021
At a glance
- Drugs Tislelizumab (Primary)
- Indications Carcinoma; Nasopharyngeal cancer
- Focus Therapeutic Use
- 27 Oct 2021 New trial record